Tumor Necrosis Factor Receptor Superfamily, Member 1B Haplotypes Increase or Decrease the Risk of Inflammatory Bowel Diseases in a New Zealand Caucasian Population : Table 6

]>Tumor Necrosis Factor Receptor Superfamily, Member 1B Haplotypes Increase or Decrease the Risk of Inflammatory Bowel Diseases in a New Zealand Caucasian Population : Table 6

Table 6: Haplotype analysis of three-SNP TNFRSF1B haplotype in IBD status in New Zealand IBD patients and Caucasians.


	Haplotype	Case frequency	Control frequency	Hap frequency	Hap-score	P-value	Global score statistics

CD	Three SNPs TNFRSF1B region (rs1061622, rs1061624, rs3397)
	GAC	0.057	0.101	0.075	−1.55	.12	= 29.9, df = 7, P = .0001
	GAT	0.048	0.050	0.051	0.09	.93
	GGC	0.091	0.031	0.064	2.78	.005
	GGT	0.039	0.033	0.036	0.77	.44
	TAC	0.210	0.277	0.241	−1.88	.06
	TAT	0.172	0.064	0.122	3.29	.001
	TGC	0.238	0.209	0.224	0.16	.88
	TGT	0.145	0.236	0.186	−1.90	.06
UC	Three SNPs TNFRSF1B region (rs1061622, rs1061624, rs3397)
	GAC	0.067	0.101	0.078	−0.92	.36	= 46.3, df = 7, P < .0001
	GAT	0.057	0.050	0.056	0.43	.67
	GGC	0.091	0.031	0.067	3.32	<.0001
	GGT	0.036	0.033	0.034	0.63	.53
	TAC	0.179	0.277	0.278	−2.81	.005
	TAT	0.170	0.064	0.128	2.76	.006
	TGC	0.289	0.209	0.259	1.75	.08
	TGT	0.112	0.236	0.159	−3.40	.0007